CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Cincinnati, Ohio, United States and 31 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...
Phase 2
Edgewood, Kentucky, United States and 13 other locations
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer...
Phase 2
Cincinnati, Ohio, United States and 14 other locations
with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...
Phase 2
Dayton, Ohio, United States of America and 42 other locations
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...
Phase 3
Cincinnati, Ohio, United States and 257 other locations
of tumor and/or stromal area of infiltrating lymphocytes prior to initiation of standard neoadjuvant chemotherapy. At enrollment, patients ...
Phase 2
Edgewood, Kentucky, United States and 3 other locations
This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...
Phase 3
Cincinnati, Ohio, United States and 163 other locations
ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...
Phase 3
Cincinnati, Ohio, United States and 462 other locations
for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previou...
Phase 3
Cincinnati, Ohio, United States of America and 165 other locations
the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer...
Phase 3
Cincinnati, Ohio, United States and 166 other locations
Clinical trials
Research sites
Resources
Legal